Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia

DSpace Repository

Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia

Author: Tandler, Claudia; Schmidt, Moritz; Heitmann, Jonas S.; Hierold, Julia; Schmidt, Jonas; Schneider, Pascal; Doerfel, Daniela; Walz, Juliane; Salih, Helmut R.
Tübinger Autor(en):
Tandler, Claudia
Schmidt, Moritz
Heitmann, Jonas S.
Hierold, Julia
Schmidt, Jonas
Dörfel, Daniela
Walz, Juliane Sarah
Salih, Helmut Rainer
Published in: Cancers (2020), Bd. 12, Article 2725
Verlagsangabe: Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers12102725
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)